PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Maryland MedicaidMedicaid · Coverage · Provider Transmittal · MD · Psychiatry, Family Medicine, Internal MedicineMedium impact

Coverage of Buprenorphine Injection

Act
immediately
Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

Maryland Medicaid has updated coverage policies for buprenorphine injection, a medication used for opioid use disorder treatment. This affects billing and coverage requirements for providers administering this medication to Maryland Medicaid patients.

Get alerts when payers change rules like this one

We check Maryland Medicaid and other payers every day and email you when a change matches your specialty and state.

Get Maryland Medicaid alertsPolicy Monitoring is free. No card required.

What to do

immediately · 2 steps
01Review the full policy document at the provided URL to understand specific coverage criteria, prior authorization requirements, and billing procedures for buprenorphine injection for Maryland Medicaid patients.
02Update billing workflows and staff training accordingly based on the detailed policy requirements.

Original notice

Coverage of Buprenorphine Injection
health.maryland.gov · The payer's link may no longer work.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account